Forging a position as an innovative player in
infectious disease vaccines and therapies

Home
About
Our Technology
Business Development
- Partner Network
- Licensing Strategy and Available Licenses
Investor Relations
Contact Us
- Corporate directory

BioDiem » » Opal acquisition of Formulytica – Capital raising

Opal acquisition of Formulytica – Capital raising May 6, 2021 • Category • Author Name

Opal acquisition of Formulytica – Capital raising

Latest News

EOFY Share Valuation Information

August 10, 2026

EOFY Share Valuation Information

Read More
Half Yearly Financial Report

July 6, 2026

26-07-01 BioDiem Limited Half-year Financial Report 31Dec2025

Read More

Join our email list!

Join our email distribution list to be updated with announcements.

© Copyright 2014 BioDiem

Privacy Policy
Terms and conditions